For more than twenty years deep brain stimulation (DBS) is being used in patients with movement disorders, predominantly in refractory Parkinson's disease (PD) followed by dystonia and essential ...

The MarketWatch News Department was not involved in the creation of this content. -- Financing led by Genesys Capital with participation from Cleveland Clinic and JobsOhio Ventures -- Genesys Capital ...

Researchers at EPFL and Lausanne University Hospital (CHUV), led by professors Grégoire Courtine and Jocelyne Bloch, have achieved a major milestone in the treatment of spinal cord injuries (SCI). By ...

Medtronic Percept™ DBS therapy is the only sensing-enabled † DBS system available, allowing a physician to use data from a patient’s brain activity to personalize their treatment. Andy says Medtronic ...

“To the best of our team's knowledge, this project represents the first time an Alabama medical center has examined deep brain stimulation for depression,” said Matthew Macaluso, D.O., director of the ...

Please provide your email address to receive an email when new articles are posted on . Offering asleep or awake DBS aims to provide PD patients choice, impetus for choosing DBS therapy sooner.

Nat Clin Pract Neurol. 2008;4(8):424-426. Several factors limit the capacity of the clinical results to date to rule out DBS as a neuroprotective therapy. First, continued functional decline does not ...

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever There is no cure for debilitating ...

European approval introduces the world's only closed-loop DBS system with real-time, self-adjusting brain stimulation for people with Parkinson's disease For 30 years, people with Parkinson's disease ...

MINNEAPOLIS, Minnesota — The U.S. Food and Drug Administration approved a Medtronic deep brain stimulation treatment to treat obsessive compulsive disorder – the first deep brain stimulation treatment ...

CLEVELAND, Jan. 13, 2026 /PRNewswire/ -- Enspire DBS Therapy, Inc. ("Enspire"), a clinical-stage company developing an implantable neuromodulation therapy for post-stroke recovery, today announced ...